Skip to content

Clinical study on the combination of traditional Chinese medicine fumigation and acupoint massage for the treatment of dry eye syndrome

Clinical study on the combination of traditional Chinese medicine fumigation and acupoint massage for the treatment of dry eye syndrome

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2024000202
Enrollment
Unknown
Registered
2024-08-09
Start date
2024-01-06
Completion date
Unknown
Last updated
2024-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ophthalmology

Interventions

Experimental group:Sodium hyaluronate eye drops, 4 times a day and traditional Chinese medicine fumigation and acupoint massage
control group:Sodium hyaluronate eye drops, 4 times a day

Sponsors

Ningbo Hospital of Traditional Chinese Medicine Affiliated to Zhejiang Chinese Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1) those who met the above diagnostic criteria for dry eye and had not recently received formal dry eye treatment; 2) those who were older than 18 and younger than 70; 3) those who had good compliance; and 4) those who had signed an informed consent form by the patient or family members.

Exclusion criteria

Exclusion criteria: 1) patients younger than 18 years old or older than 70 years old; 2) patients with tear duct obstruction, tear duct ectropion and chronic dacryocystitis, ocular congenital anomalies, glaucoma, cataracts, conjunctivitis, severe infectious keratitis; 3) patients with high myopia or hyperopia; 4) patients who have had ocular surgeries in the last 3 months; 5) patients with serious diseases or dysfunction of the major organs; 6) patients with systemic immune diseases such as rheumatoid arthritis, systemic Rheumatoid arthritis, systemic lupus erythematosus, dry syndrome and other systemic immune diseases; 7) recent use of anti-inflammatory or immunosuppressant therapy; 8) patients in pregnancy or breastfeeding; 9) patients who do not want to receive Chinese medicine; 10) allergy.

Design outcomes

Primary

MeasureTime frame
Tear River Height;Schirmer I test;break-up time;questionnaire investigation;

Secondary

MeasureTime frame
fluorescent staining;Infrared imaging of meibomian gland;

Countries

CHINA

Contacts

Public ContactWANG SHIMING

Ningbo Hospital of Traditional Chinese Medicine Affiliated to Zhejiang Chinese Medical University

wsm1981711@163.com+86 188 5802 6899

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026